MarketResearchNest.com adds “Acne Vulgaris – Pipeline Review, H2 2017” new report to its research database. The report spread across in 201 pages with table and figures in it. 714 more words
Tags » Acne Vulgaris
Biotechnology company Novan Therapeutics has announced that it has received encouraging results from a phase 2b study analysing a nitric-oxide topical gel candidate drug.
SB204, which is the company’s leading drug candidate for the treatment of acne vulgaris, was used in the trial and produced significant results on inflammatory and non-inflammatory lesions at week 12 on a recorded 213 patients. 173 more words